Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Opioid Substitution Therapy in HCV Patients

J Infect Dis; ePub 2017 Dec 26; Stepanova, et al

Receiving interferon-free regimens led to patient-reported outcome (PRO) improvement during treatment for hepatitis C virus (HCV) and after SVR regardless of opioid substitution therapy (OST) status, a recent study found. Patients were enrolled in phase 3 clinical trials of sofosbuvir and completed 4 PRO instruments: SF-36V2, FACIT-F, CLDQ-HCV, and WPAI-HCV before, during, and post-treatment. 8,450 HCV individuals were included; 407 (4.8%) were on OST. Researchers found:

  • At baseline, OST participants had significantly lower PRO scores.
  • By treatment completion, those receiving IFN+RBV+SOF experienced significant decreases in PROs regardless of OST use.
  • Those receiving IFN-free RBV+ regimens had significant but smaller PRO decreases; similar in OST and non-OST.
  • Those treated with IFN/RBV-free regimens showed improvement in nearly all PROs during treatment which was more pronounced in OST individuals.


Stepanova M, Thompson A, Doyle J, Younossi I, de Avila L, Younossi ZM. Hepatitis C patients receiving opioid substitution therapy experience improvement in patient-reported outcomes following treatment with interferon-free regimens. [Published online ahead of print December 26, 2017]. J Infect Dis. doi:10.1093/infdis/jix681.

This Week's Must Reads

Difficult-to-Treat Resistance in GNBSIs, Clin Infect Dis; ePub 2018 Jul 23; Kadri, et al

Missed Opportunities for HIV Testing, Open Forum Infect Dis; ePub 2018 Jul 19; Kapadia, et al

Bacterial STI Screening Rates Among MSM, Sex Transm Dis; ePub 2018 Jul 24; Jenness, et al

Patient Engagement in HIV Care, AIDS; ePub 2018 Jul 12; Lee, Wu, et al

IDSA/ASM Lab Guide for Diagnosis of IDs, Clin Infect Dis; ePub 2018 Jun 28; Miller, et al

Must Reads in Hepatitis

Pregnancy Outcomes in Women with HBV , Open Forum Infect Dis; ePub 2018 Jun 9; Bajema, et al

HBV Prevention in Foreign-Born Women, Clin Infect Dis; ePub 2018 Jun 1; Kilmer, et al

ACIP Recommends Hepatitis B Vaccine for Adults, MMWR; 2018 Apr 20; Schillie, Harris, et al

HCV Treatment as Prevention in PWIDs, Lancet; 2018 Feb; Zelenev, Li, et al

Microbial Translocation & Immune Activation in HIV and HCV, J Infect Dis; ePub 2018 Jan 3; Reid, Ma, et al